Retatrutide

Retatrutide is a laboratory-manufactured synthetic peptide designed for advanced metabolic research. It functions as a multi-receptor agonist interacting with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, making it a subject of interest in experimental metabolic and endocrine studies.

This peptide has gained significant attention within scientific research communities due to its unique triple-agonist mechanism, allowing investigators to explore complex pathways involved in energy balance, metabolic regulation, and hormonal signalling.

Current scientific literature and preclinical investigations have explored Retatrutide in experimental models related to:

• Metabolic signalling and energy regulation pathways
•  Hormonal receptor interaction studies involving GLP-1, GIP, and glucagon receptors
• Experimental glucose metabolism models
• Appetite regulation signalling pathways
• Energy expenditure and metabolic pathway research

Retatrutide is increasingly utilised by laboratories studying the effects of multi-pathway peptide signalling within controlled research environments.

Intended Use: Product supplied strictly as an investigational research compound. It is not approved by the FDA, TGA, or any regulatory authority for therapeutic, diagnostic, or medicinal use. Not for human or animal consumption.

Compound Type: Synthetic peptide
Vial Content: 10mg per vial
Format: Lyophilized (freeze-dried) powder
Analytical Purity: ≥ 98%
Physical Appearance: White to off-white fine powder

Storage Guidelines

• Keep sealed until experimental use
• Store protected from heat and moisture
• Refrigerated storage recommended for enhanced stability

Laboratory Handling

• Reconstitute with a sterile laboratory-grade diluent
• Use standard aseptic laboratory techniques during preparation and handling

Research Applications
Commonly employed in preclinical studies examining:

• Multi-receptor metabolic signalling pathways
• GLP-1, GIP, and glucagon receptor interaction research
• Experimental metabolic regulation models
• Hormonal signalling pathway investigations
• Energy balance and endocrine signalling research

Intended Use: Supplied strictly as laboratory research material only. Not approved for therapeutic use or for human/animal consumption.

For reference, here is a link to a peer-reviewed scientific publication exploring the biological activity of Retatrutide and related multi-receptor peptide compounds in controlled experimental settings. The research provides insight into their molecular interactions, signaling pathways, and potential mechanisms of action in metabolic and cellular systems.
Read the Research

Retatrutide is an investigational peptide being studied for its activity across GLP-1, GIP and glucagon receptor pathways. Research is examining its receptor activity, metabolic signalling, molecular behaviour and peptide stability.

Retatrutide remains under investigation and is supplied by Elite Peptides West for laboratory and research purposes only. It is not supplied for human consumption, medical treatment, diagnosis or therapeutic use.

Researchers can also review available Certificates of Analysis and laboratory documentation for additional product information.

View our COAs for laboratory testing information.